Key insights
- Avalon GloboCare's shareholders approved board authority for a potential reverse stock split. While no split is planned currently, the authorization gives the board flexibility. The company raised $3.25M via private placement. This news has a slightly negative influence as reverse stock splits are often perceived negatively by the market.
Avalon GloboCare Corp. (NASDAQ:ALBT) announced Monday that its shareholders approved several proposals related to the company’s capital structure, including authorization for the board of directors to implement a reverse stock split in the future if deemed appropriate. The announcement was made through a press release statement and disclosed on the company’s social media channels.
According to the company, the approval took place on March 30, 2026. Avalon GloboCare stated that the authorization does not mean a reverse stock split is being implemented at this time, and there is currently no reverse stock split planned. The company said the authorization provides the board with flexibility to act in the future if it determines such a move is in the best interest of the company and its shareholders.
Avalon GloboCare described the authorization as a standard governance measure intended to maintain optionality as the company evaluates its strategic and corporate priorities.
The company also noted that it uses various social media channels, including Stocktwits, X, Yahoo Finance, and Reddit, to disseminate public information to investors, the media, and other interested parties. Avalon GloboCare encouraged stakeholders to review information posted on these channels, as it could be considered material.
Avalon GloboCare’s common stock is listed on the Nasdaq Stock Market under the symbol ALBT. The information in this article is based on a press release statement and a filing with the U.S. Securities and Exchange Commission.
In other recent news, Avalon GloboCare Corp. has announced several significant developments. The company successfully closed a private placement offering, raising approximately $3.25 million in gross proceeds. This offering involved the sale of 6,372,550 shares of common stock or pre-funded warrants, priced at $0.51 per share, along with Series A-1 and Series A-2 warrants. In a related update, Avalon GloboCare has been accepted into the Advanced Micro Devices AI Developer Program, granting it access to valuable resources for artificial intelligence development. This includes AMD Developer Cloud credits and advanced tools, which will be utilized by Avalon Quantum AI LLC, a subsidiary of Avalon GloboCare. Additionally, the company has partnered with Caylent, Inc., an AWS Premier Tier Consulting Partner, to enhance its Catch-Up video platform into an autonomous AI-driven system. These recent developments reflect Avalon’s ongoing efforts to advance its technology and expand its capabilities in the AI domain.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.